Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003844652 | SCV004648914 | pathogenic | Catecholaminergic polymorphic ventricular tachycardia 1 | 2023-02-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp325Glyfs*7) in the CASQ2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 75 amino acid(s) of the CASQ2 protein. This variant is present in population databases (no rsID available, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with CASQ2-related conditions. This variant disrupts a region of the CASQ2 protein in which other variant(s) (p.W361*) have been determined to be pathogenic (PMID: 23595086, 30729048). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |